Study of Darbepoetin Alfa for the Treatment of Anemia of Cancer

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Amgen
ClinicalTrials.gov Identifier:
NCT00091858
First received: September 17, 2004
Last updated: May 6, 2013
Last verified: May 2013